JAVMA news
Webinar explains federal guidance on manufacturing of animal cells and tissues
The Food and Drug Administration posted a prerecorded webinar this fall explaining draft guidance documents on good manufacturing practices and donor…
policy
Development of emerging disease agent biologics
Development of emerging infectious disease biologics is essential for One Health. The AVMA supports the development of these products through…
policy
Adverse event reporting
The AVMA encourages veterinarians to report adverse events, and encourages continued development and strengthening of adverse event reporting systems.
JAVMA news
Academic groups seek easier approval path for gene-edited food animals
Two academic groups argue that the amount of regulatory oversight for genetic changes in food animals should depend on the nature of the changes, and…
JAVMA news
Pig ears still a Salmonella risk despite interventions
Pig ear treats remain a source of Salmonella after decades of illnesses.
JAVMA news
The risky business of global animal movement
Likely sources of another pandemic are being scrutinized like never before, including the global movement of animals via international trade and…
AVMA news
Advances in animal genome editing continue apace
The Food and Drug Administration (FDA) recently green lit for human consumption five genetically modified pigs at Washington State University.…
AVMA news
K-State funded for new African swine fever studies
Kansas State University researchers will conduct a $500,000-plus research project to examine how African swine fever virus survives and spreads on…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…